Georgiana Nemeti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Georgiana Nemeti has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Muresan
Obstetrics and Gynecology I, Mother and Child Department, University of Medicine and Pharmacy “Iuliu Hatieganu”, 400006 Cluj-Napoca, Romania
3 shared publications - Mihai Surcel
Obstetrics and Gynecology I, Mother and Child Department, University of Medicine and Pharmacy “Iuliu Hatieganu”, 400006 Cluj-Napoca, Romania
3 shared publications - Adelina Staicu
1st Department of Obstetrics and Gynecology, “Iuliu Haţieganu” University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania
2 shared publications - Dan Boitor-Borza
Department of Obstetrics and Gynecology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
2 shared publications - Ioana Cristina Rotar
Obstetrics and Gynecology I, Mother and Child Department, University of Medicine and Pharmacy “Iuliu Hatieganu”, 400006 Cluj-Napoca, Romania
2 shared publications - Mihaela Oancea
Department of Obstetrics and Gynecology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
2 shared publications
Latest Publications
- Open Access
Cognitive Tunneling in Obstetrics and Gynecology: A Critical Review of Implications for Clinical Practice and Mitigation Strategies
Cognitive tunnelling poses significant risks in OB/GYN, where rapid clinical deterioration and time-pressured decision-making are common. This critical review synthesized evidence from a comprehensive literature search across multiple databases, yielding 414 unique papers examining cognitive tunnelling mechanisms, patient safety consequences, and mitigation strategies in obstetric and gynecological contexts. Medicolegal analysis reveals that cognitive tunnelling contributes to malpractice exposure and that adoption of structured safety programs addresses root causes and strengthens the clinical record for forensic review. Mitigation strategies were critically evaluated: metacognition and individual cognitive forcing strategies such as DECLARE (Differential, Examine, Consider, List, Assess, Review, Evaluate) and Pivot-and-Cluster show theoretical promise but depend on intact executive capacity that is depleted under the very conditions that precipitate tunnelling; debriefing demonstrates consistent improvements in team situational awareness and latent threat identification but requires organizational just culture and psychological safety; and hierarchical closed-loop communication systems provide the strongest evidence of reducing preventable adverse events by distributing attentional load across teams, though authority gradients risk suppressing junior-staff dissent. Despite growing recognition, significant knowledge gaps remain regarding measurement methodologies, obstetric-specific research, intervention effectiveness, and the integration of emerging artificial intelligence technologies. Addressing cognitive tunneling through quality studies with patient-centered outcomes and validated measures is essential for reducing medical errors and enhancing patient safety in women’s healthcare.
Open AccessCognitive Tunneling in Obstetrics and Gynecology: A Critical Review of Implications for Clinical Practice and Mitigation Strategies
Cognitive tunnelling poses significant risks in OB/GYN, where rapid clinical deterioration and time-pressured decision-making are common. This critical review synthesized evidence from a comprehensive literature search across multiple databases, yielding 414 unique papers examining cognitive tunnelling mechanisms, patient safety consequences, and mitigation strategies in obstetric and gynecological contexts. Medicolegal analysis reveals that cognitive tunnelling contributes to malpractice exposure and that adoption of structured safety programs addresses root causes and strengthens the clinical record for forensic review. Mitigation strategies were critically evaluated: metacognition and individual cognitive forcing strategies such as DECLARE (Differential, Examine, Consider, List, Assess, Review, Evaluate) and Pivot-and-Cluster show theoretical promise but depend on intact executive capacity that is depleted under the very conditions that precipitate tunnelling; debriefing demonstrates consistent improvements in team situational awareness and latent threat identification but requires organizational just culture and psychological safety; and hierarchical closed-loop communication systems provide the strongest evidence of reducing preventable adverse events by distributing attentional load across teams, though authority gradients risk suppressing junior-staff dissent. Despite growing recognition, significant knowledge gaps remain regarding measurement methodologies, obstetric-specific research, intervention effectiveness, and the integration of emerging artificial intelligence technologies. Addressing cognitive tunneling through quality studies with patient-centered outcomes and validated measures is essential for reducing medical errors and enhancing patient safety in women’s healthcare.
- Open Access
- 29 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 1026
Potential Benefits of Ultra-High Field MRI for Embryonic and Fetal Brain Investigation: A Comprehensive Review
Ultra-high-field (UHF) magnetic resonance imaging, defined as imaging at field strengths of 7 Tesla (7T) and above, represents a frontier technology in neuroimaging with emerging applications in prenatal brain research. This narrative review examines the current evidence on the potential benefits of UHF-MRI for investigating embryonic and fetal brain development. Through analysis of 97 studies identified across multiple databases, we find that UHF-MRI offers substantial advantages in spatial resolution, tissue contrast, and anatomical detail compared to conventional clinical field strengths (1.5T and 3T). The primary applications to date have been in ex vivo imaging of post-mortem fetal specimens and preclinical animal models, where UHF-MRI has enabled unprecedented visualization of laminar cortical organization, early sulcation patterns, microstructural development, and subtle anatomical features critical for understanding normal and abnormal neurodevelopment. Key benefits include enhanced delineation of transient developmental zones, improved characterization of cortical folding, superior detection of subtle malformations, and the ability to create high-resolution three-dimensional atlases of fetal brain development. However, significant technical and safety challenges currently limit in utero human applications, including concerns about specific absorption rate, acoustic noise, and fetal motion artifacts. This review identifies critical knowledge gaps and future directions for translating UHF-MRI technology to clinical prenatal diagnostics.
- 29 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 1026
Open AccessPotential Benefits of Ultra-High Field MRI for Embryonic and Fetal Brain Investigation: A Comprehensive Review
Ultra-high-field (UHF) magnetic resonance imaging, defined as imaging at field strengths of 7 Tesla (7T) and above, represents a frontier technology in neuroimaging with emerging applications in prenatal brain research. This narrative review examines the current evidence on the potential benefits of UHF-MRI for investigating embryonic and fetal brain development. Through analysis of 97 studies identified across multiple databases, we find that UHF-MRI offers substantial advantages in spatial resolution, tissue contrast, and anatomical detail compared to conventional clinical field strengths (1.5T and 3T). The primary applications to date have been in ex vivo imaging of post-mortem fetal specimens and preclinical animal models, where UHF-MRI has enabled unprecedented visualization of laminar cortical organization, early sulcation patterns, microstructural development, and subtle anatomical features critical for understanding normal and abnormal neurodevelopment. Key benefits include enhanced delineation of transient developmental zones, improved characterization of cortical folding, superior detection of subtle malformations, and the ability to create high-resolution three-dimensional atlases of fetal brain development. However, significant technical and safety challenges currently limit in utero human applications, including concerns about specific absorption rate, acoustic noise, and fetal motion artifacts. This review identifies critical knowledge gaps and future directions for translating UHF-MRI technology to clinical prenatal diagnostics.
- Open Access
- 29 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (10) , 2371
Impact of Follicle Stimulating Hormone Receptor (FSHR) Polymorphism on the Efficiency of Co-Treatment with Growth Hormone in a Group of Infertile Women from Romania
“Poor responders” (PR) are an important category of infertile women who experience a modest response to controlled ovarian stimulation. In this study, we evaluated response to growth hormone (GH) administration among PR patient subtypes stratified by follicle stimulation hormone receptor (FSHR) polymorphism (c.2039A > G p.Asn680Ser). We conducted a cohort study of 125 women with poor ovarian response, 58 of whom received GH in addition to the standard treatment, and 67 of whom received the standard treatment only. The Ala307Thr polymorphism genotypes were analyzed using a polymerase chain reaction-restriction fragment length polymorphism method, and the FSHR gene polymorphism was analyzed using a predesigned TaqMan SNP Genotyping Assay (rs6166). A comparative analysis detected statistically significant differences in mean mature follicles (p = 0.0002), metaphase-II oocytes (p = 0.0005), progesterone levels (p = 0.0036), and IGF levels (follicle IGF1, p = 0.0004) between GH-treated and non-GH-treated participants with the FSHR (Ser/Ser) polymorphism. However, the differences were modest among participants with the other two FSHR polymorphisms (Ser/Asn and Asn/Asn). The subcategory of patients with the FSHR Asn680Ser (Ser/Ser) polymorphism showed a stronger response when GH was added to the IVF protocol.
- 29 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (10) , 2371
Open AccessImpact of Follicle Stimulating Hormone Receptor (FSHR) Polymorphism on the Efficiency of Co-Treatment with Growth Hormone in a Group of Infertile Women from Romania
“Poor responders” (PR) are an important category of infertile women who experience a modest response to controlled ovarian stimulation. In this study, we evaluated response to growth hormone (GH) administration among PR patient subtypes stratified by follicle stimulation hormone receptor (FSHR) polymorphism (c.2039A > G p.Asn680Ser). We conducted a cohort study of 125 women with poor ovarian response, 58 of whom received GH in addition to the standard treatment, and 67 of whom received the standard treatment only. The Ala307Thr polymorphism genotypes were analyzed using a polymerase chain reaction-restriction fragment length polymorphism method, and the FSHR gene polymorphism was analyzed using a predesigned TaqMan SNP Genotyping Assay (rs6166). A comparative analysis detected statistically significant differences in mean mature follicles (p = 0.0002), metaphase-II oocytes (p = 0.0005), progesterone levels (p = 0.0036), and IGF levels (follicle IGF1, p = 0.0004) between GH-treated and non-GH-treated participants with the FSHR (Ser/Ser) polymorphism. However, the differences were modest among participants with the other two FSHR polymorphisms (Ser/Asn and Asn/Asn). The subcategory of patients with the FSHR Asn680Ser (Ser/Ser) polymorphism showed a stronger response when GH was added to the IVF protocol.